<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page14.png"">
<div class="txt" style="position:absolute; left:253px; top:89px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Ministry of Health - MS</span></div>
<div class="txt" style="position:absolute; left:196px; top:103px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">National Health Surveillance Agency </span><span class="f2" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">– </span><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">ANVISA</span></div>
<div class="txt" style="position:absolute; left:144px; top:131px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 16. Changes to information presented in the medical device</span></div>
<div class="txt" style="position:absolute; left:84px; top:146px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">notification or registration process are classified under:</span></div>
<div class="txt" style="position:absolute; left:145px; top:168px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">I - amendment of approval required;</span></div>
<div class="txt" style="position:absolute; left:145px; top:190px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">II - Immediate implementation change; and</span></div>
<div class="txt" style="position:absolute; left:145px; top:212px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">III - Non-reportable change.</span></div>
<div class="txt" style="position:absolute; left:144px; top:234px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 1 The petitioning of the amendments contained in paragraphs I and II of</span></div>
<div class="txt" style="position:absolute; left:84px; top:249px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">this article shall comply with the provisions of the Normative Instruction - IN No. 74, of</span></div>
<div class="txt" style="position:absolute; left:84px; top:263px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">September 16, 2020, published in DOU No. 180, of September 18, 2022, Section 1, p.</span></div>
<div class="txt" style="position:absolute; left:84px; top:278px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">111, which details the applicable petitioning subjects.</span></div>
<div class="txt" style="position:absolute; left:144px; top:300px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 2º Any minor changes not classified as required approval or immediate</span></div>
<div class="txt" style="position:absolute; left:84px; top:315px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">implementation are classified as non-reportable changes, and also: Changes in</span></div>
<div class="txt" style="position:absolute; left:84px; top:329px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">information that do not modify the medical device design; bug fixes in software; Non-</span></div>
<div class="txt" style="position:absolute; left:84px; top:344px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">technical changes such as images, formatting, layouts, symbols and text adaptations of</span></div>
<div class="txt" style="position:absolute; left:84px; top:359px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">documents without additional risk; updates of company operating authorization</span></div>
<div class="txt" style="position:absolute; left:84px; top:374px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">information; changes of contact (e.g. telephone numbers or postal address), technical</span></div>
<div class="txt" style="position:absolute; left:84px; top:389px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">assistance and website.</span></div>
<div class="txt" style="position:absolute; left:144px; top:410px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 3 The amendments related to §2 shall be controlled by the quality system</span></div>
<div class="txt" style="position:absolute; left:84px; top:425px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">of the regularization holder and be incorporated into subsequent petitions.</span></div>
<div class="txt" style="position:absolute; left:144px; top:447px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 4º The change petitioning for medical devices of risk classes I and II will</span></div>
<div class="txt" style="position:absolute; left:84px; top:462px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">be performed by the immediate implementation regime, except when it is a non-</span></div>
<div class="txt" style="position:absolute; left:84px; top:477px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">reportable change.</span></div>
<div class="txt" style="position:absolute; left:144px; top:498px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 17. The subjects of petition for change of notification or registration of</span></div>
<div class="txt" style="position:absolute; left:84px; top:513px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">medical devices are provided by Normative Instruction - IN No. 74, of September 16,</span></div>
<div class="txt" style="position:absolute; left:84px; top:528px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">2020, which identifies the changes that are considered as required approval or</span></div>
<div class="txt" style="position:absolute; left:84px; top:543px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">immediate implementation.</span></div>
<div class="txt" style="position:absolute; left:144px; top:565px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 18. The request to change information must be accompanied by</span></div>
<div class="txt" style="position:absolute; left:84px; top:579px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">documentation proving the modification to be implemented, in accordance with the</span></div>
<div class="txt" style="position:absolute; left:84px; top:594px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">current health legislation.</span></div>
<div class="txt" style="position:absolute; left:144px; top:616px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 19. The immediate implementation change that is interdependent</span></div>
<div class="txt" style="position:absolute; left:84px; top:631px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">with the required approval change should be requested in conjunction with this</span></div>
<div class="txt" style="position:absolute; left:84px; top:645px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">amendment, incorporating its content.</span></div>
<div class="txt" style="position:absolute; left:144px; top:667px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 20. Changes resulting from field action notified to Anvisa in order to</span></div>
<div class="txt" style="position:absolute; left:84px; top:682px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">ensure the safety and performance of the device in relation to the user and the patient</span></div>
<div class="txt" style="position:absolute; left:84px; top:697px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">will have their analyzes prioritized.</span></div>
<div class="txt" style="position:absolute; left:145px; top:782px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);">This text does not replace the published in the Official Gazette.</span></div>
</body>
</html>
